REVEAL INSERTABLE LOOP RECORDER (ILR) SYSTEM

K972242 · Medtronic Vascular · MXC · Jan 16, 1998 · Cardiovascular

Device Facts

Record IDK972242
Device NameREVEAL INSERTABLE LOOP RECORDER (ILR) SYSTEM
ApplicantMedtronic Vascular
Product CodeMXC · Cardiovascular
Decision DateJan 16, 1998
DecisionST
Submission TypeTraditional
Regulation21 CFR 870.2800
Device ClassClass 2

Intended Use

The Medtronic Model 9525 Reveal™ Insertable Loop Recorder is an implantable, patient-activated monitoring system that records subcutaneous ECG and is designed for diagnostic evaluation of patients who experience transient symptoms that may suggest a cardiac arrhythmia.

Device Story

The Reveal ILR system consists of an implantable recorder (Model 9525) and a handheld patient activator (Model 6190). The device is implanted subcutaneously to continuously monitor and record subcutaneous ECG signals. When a patient experiences symptoms, they use the activator to signal the recorder to store the ECG data from a pre-determined period before and after the event. Data is retrieved by a clinician using a programmer (Model 9790) with a telemetry head and specialized software (Model 9802E). The retrieved ECG waveforms are displayed on the programmer screen, printed, or saved to disk for clinical evaluation. This system assists physicians in diagnosing transient cardiac arrhythmias by providing documented ECG evidence of symptomatic events, enabling informed clinical decision-making regarding patient treatment.

Clinical Evidence

No human clinical data provided. Evidence consists of in vitro bench testing (hybrid qualification, electromagnetic compatibility, mechanical, battery, and package testing) and in vivo canine comparative studies. Canine studies compared the Reveal ILR to surface ECG monitors and competitive cardiac event recorders (Instromedix King of Hearts Express 3X and HeartCard 3X), demonstrating safe operation and equivalent ECG performance.

Technological Characteristics

Implantable subcutaneous recorder; 61 x 19 x 8 mm; 17g; 8cc volume. Materials identical to Medtronic Minix IPG. Sensing: subcutaneous ECG electrode. Sampling rate: 100 Hz (stored at 50 Hz). Bandwidth: 0.85-32 Hz. Connectivity: RF telemetry via programmer. Power: Implantable battery. Sterilization: 100% Ethylene Oxide (EtO).

Indications for Use

Indicated for patients experiencing transient symptoms suggestive of cardiac arrhythmia.

Regulatory Classification

Identification

A medical magnetic tape recorder is a device used to record and play back signals from, for example, physiological amplifiers, signal conditioners, or computers.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K972242 # 510(k) SUMMARY ### Submitter JAN | 6 |998 Medtronic, Inc. 7000 Central Avenue N.E. Minneapolis, MN 55432 Contact: Nora K. Hadding, Product Regulation Manager Telephone: (612) 514-4189 Fax: (612) 514-6424 E-Mail: nora.hadding@medtronic.com Date Prepared: June 13, 1997 ### Name of Device Trade Name: "Reveal™ Insertable Loop Recorder" (ILR) System. The system is composed of the Model 9525 implanted recorder and the Model 6190 Activator. The Model 9802E Reveal software, Model 9790 programmer and Model 9766A telemetry head are also part of the system. Common Name: insertable loop recorder Classification Name: The Reveal Insertable Loop Recorder (ILR) system is a combination of existing devices. The classification names and numbers of these devices are: - "Telephone electrocardiograph transmitter and receiver" (870.2920) (Class II) . - "Implantable pacemaker pulse generator" (870.3610) (Class III) . ### Predicate Devices Table 1. Reveal ILR System - Predicate Devices | Product | Features Similar to the Reveal ILR System | |--------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Instromedix King of Hearts Express® 3X™ Model<br>5328-00 (cardiac event recorder-looping memory) | • Ambulatory event recorder<br>• Continuous ECG recording<br>• Looping memory<br>• Pre- and post-event storage<br>• Patient-activated | | Medtronic Minix Model 8341M (single-chamber<br>implantable pulse generator) | • Implantable<br>• Dimensions<br>• Subcutaneous electrode (in unipolar mode)<br>• Programmable via a programmer unit<br>• Transmit real time ECG waveform<br>• Data retrieval (radio-frequency telemetry) | {1}------------------------------------------------ ## Device Description #### System Description The Reveal ILR system is designed to record and store subcutaneous electrocardiogram (ECG) during symptomatic events. The system consists of the Model 9525 implanted recorder and the Model 6190 Activator. A Medtronic Model 9790 programmer equipped with a Medtronic Model 9766A radio frequency telemetry head and Model 9802E software is required for programming and retrieving data from the recorder. ### Model 9525 Implanted Recorder The implanted recorder is a single-use, programmable device which is constructed of the same tissue-contacting materials used in Medtronic pacemakers. The implanted recorder is designed for long-term subcutaneous implantation. The implanted recorder is programmed using a Medtronic Model 9790 programmer. It continually records subcutaneous ECG into its looping memory and stores recorded ECG when signaled by the Activator. ### Model 6190 Activator The Activator is a hand-held, battery-operated telemetry device that communicates with the implanted recorder through the skin. It is used to signal the implanted recorder to store ECG recorded during a symptomatic event, for later retrieval and evaluation. The Activator is designed to be used during symptoms or immediately after symptoms. When the Activator is placed over the implanted recorder and the Activator button is pushed, the implanted recorder stores the ECG recorded during a pre-determined period of time before and after the Activator is used. Stored ECG is retrieved via telemetry using a Medtronic programmer. The retrieved ECG can be viewed on the programmer screen, printed, or saved to disk. Stored ECG is erased and the recorder is restarted for continued use with a Medtronic programmer. #### Programmer Reveal Model 9802E software is loaded onto the Medtronic Model 9790 programmer. The programmer, with the Model 9766A radio frequency (RF) telemetry programming head, is used to communicate with the implanted recorder. The programmer uses radio frequency (RF) telemetry to transmit to and receive data from the implanted recorder and is used to program parameters of the implanted recorder, and to retrieve and display stored events for analysis. #### Software Reveal Model 9802E software is run from the Model 9790 programmer. It allows the clinician to program parameters of the recorder and to retrieve stored events for analysis. The clinician may select one of four modes for data storage. When the device memory is full, the software is used to erase stored events and restart recording for continued use. When event(s) are stored in the implanted recorder's memory, the clinician may retrieve these event(s). The clinician can view the stored event on the programmer screen or print all or portions of the waveform to the programmer printer or to a full size external printer. {2}------------------------------------------------ The events can also be saved on a diskette for later use. This allows the clinician to read the events from diskette at a later time when the patient and device are not present. At that time, events can be analyzed on the programmer screen or printed. ### Packaging Two package configurations are available. The ILR system package contains the implanted recorder, the Activator, and the product information manual. A replacement Activator is available in the other package configuration. Both package configurations were fully validated. # Intended Use The Medtronic Model 9525 Reveal Insertable Loop Recorder is an implantable, patientactivated monitoring system that records subcutaneous ECG and is designed for diagnostic evaluation of patients who experience transient symptoms that may suggest a cardiac arrhythmia. # Technological Characteristics The technology used with the Reveal ILR system is similar to several devices currently available on the market. The table on the following page outlines the functional similarities between the Reveal ILR system and the identified predicate devices. | Device Feature | Reveal™ ILR | Instromedix<br>King of Hearts | Medtronic<br>Minix™ IPG | |--------------------------------------|------------------------------|--------------------------------------|---------------------------| | ECG Recorder | Yes | Yes | No | | Real-time<br>Waveforms | Yes | No | Yes | | Looping Memory | Yes | Yes | No | | Implantable | Yes | No | Yes | | Pre and Post Event<br>Storage | Yes | Yes | No | | Subcutaneous<br>Electrode | Yes | No | Yes<br>(in unipolar mode) | | Patient-Activated | Yes | Yes | No | | Implantable Battery | Yes | No | Yes | | Total Storage Time | 42 min.* | 5 min. | No | | Maximum Single<br>Event Storage Time | 42 min. | 5 min. | N/A | | Storage Modes | 4 modes | Programmable | N/A | | Number of Events | 1 or 3 | Up to 60 | N/A | | Data Retrieval | Radio-frequency<br>telemetry | Transtelephonic<br>or audio-coupling | Radio-frequency telemetry | | Bandwidth | 0.85-32 Hz | 0.05-30 Hz | N/A | | Sampling Rate | 100 Hz | 218 Hz | N/A | | Volume | 8 cc | N/A | 10.4 cc | | Mass | 17 g | N/A | 24.8 g | | Dimensions | 61 x 19 x 8 mm | N/A | 50x14x6 mm | *ECG waveforms stored in modes with a total storage time to increase storage time. Data sampled at 100Hz is stored to memory at 50Hz. {3}------------------------------------------------ # Summary of Studies The following studies were performed to ensure that the Reveal ILR system meets all of its design and performance requirements. ### In Vitro/Bench Testing To evaluate the Reveal ILR system, the following in vitro testing was completed: - Model 9525 implanted recorder testing (hybrid qualification testing, electromagnetic . compatibility testing, mechanical testing, and battery testing) - Model 6190 Activator testing . - . Package testing The Reveal ILR system passed all of the in vitro requirements. ### In Vivo Canine Testing Two comparative studies of the Reveal ILR system were performed with canines. One study compared the Reveal ILR system to a surface ECG monitor. The other study compared the Reveal ILR system to a surface monitor and two competitive devices currently available: the Instromedix King of Hearts Express® 3X™ and the Instromedix HeartCard 3X™ (cardiac event recorders). The data generated by these studies demonstrate that the Reveal ILR system is safe and provides ECG information which is substantially equivalent to that provided by the surface monitor and cardiac event recorders. ### Biocompatibility Information Biocompatibility testing was not required because blood-contacting materials of the Reveal ILR implanted device are the same as the Medtronic Minix implantable pulse generator. #### Sterilization Validation The Model 9525 implanted recorder is sterilized using a 100% Ethylene Oxide (EtO) sterilization process. A process appropriate for sterilizing the Model 9525 implanted recorder was validated. ## Conclusion The testing described above provides reasonable assurance that the Reveal ILR system will perform as intended when used in accordance with its labeling. Additionally, based on similarities in design, materials, in vitro test data and canine in vivo electrical performance, Medtronic considers the Reveal ILR system to be substantially equivalent to these pre-regulation devices: the Instromedix King of Hearts Express 3X, and the Medtronic Minix implantable pulse generator. {4}------------------------------------------------ Image /page/4/Picture/2 description: The image is a simple, high-contrast, black and white image. A thin, dark line stretches horizontally across the upper portion of the frame. The rest of the image is a blank white space. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ### FEB 23 1999 Ms. Nora K. Hadding Cardiac Pacing Business Medtronic, Inc. 7000 Central Avenue, N.E. Minneapolis, MN 55432-3576 Re: K972242 The Reveal™ Insertable Loop Recorder System including the Model 9525 Implantable Recorder and the Model 6190 Patient Activator Requlatory Class: II (two) Product Code: 74 MXC Dated: October 17, 1997 Received: October 20, 1997 Dear Ms. Hadding: This letter corrects our substantially equivalent letter of January 16, 1998, regarding the Reveal™ Insertable Loop Recorder We believe that the product code and regulatory classification System. of the device should have been 74 MXC/II(two). We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General (QS) regulation (21 CFR Part 820) and that, through periodic QS {5}------------------------------------------------ Page 2 - Ms. Nora K. Hadding inspections, FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to continue marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at their toll free number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, DA Speyh Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health {6}------------------------------------------------ ### Indications for Use : ・ ・ | 510(k) Number (if known): | N/A | K972242 | |---------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------| | Device Name: | Reveal <sup>TM</sup> Insertable Loop Recorder System | | | Indications For Use: | The Medtronic Model 9525 Reveal <sup>TM</sup> Insertable Loop Recorder is an implantable, patient-activated monitoring system that records subcutaneous ECG and is indicated for patients who experience transient symptoms that may suggest a cardiac arrhythmia. | | ### (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) | Concurrence of CDRH, Office of Device Evaluation (ODE) | | | |---------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------|----------------------| | | (Division Sign-Off)<br>Division of Cardiovascular<br>and Neurological Devices<br>510(k) Number | | | Prescription Use <span style="font-size: 2em;">✓</span><br>(Per 21 CFR 801.109) | OR | Over-The-Counter Use | | Thomas J. Callahan | | | (Optional Format 1-2-96)
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...